|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Other interest-earning cash equivalents | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities, available for sale | ||||||||||||||||||||
| Mortgage loans held for sale at fair value | ||||||||||||||||||||
| Loans, gross | ||||||||||||||||||||
| Mortgage Receivable | ||||||||||||||||||||
| Other Loans | ||||||||||||||||||||
| Real Estate Loans | ||||||||||||||||||||
| Deferred loan expenses, net | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Mortgages | ||||||||||||||||||||
| Other Loans | ||||||||||||||||||||
| Deferred Loan Expense | ||||||||||||||||||||
| Real Estate Loans | ||||||||||||||||||||
| Total loans held for investment | ||||||||||||||||||||
| Allowance for Credit Loss on Loans, Beginning Balance | ||||||||||||||||||||
| Allowance for credit losses on loans | ||||||||||||||||||||
| Loans, net | ||||||||||||||||||||
| Mortgage loan servicing rights, net | ||||||||||||||||||||
| Federal Home Loan Bank stock, at cost | ||||||||||||||||||||
| Real estate owned, net | ||||||||||||||||||||
| Premises, equipment, and software, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Bank owned life insurance contracts | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Preferred stock, par value | ||||||||||||||||||||
| Preferred stock, shares authorized | ||||||||||||||||||||
| Preferred stock, shares issued | ||||||||||||||||||||
| Preferred stock, shares outstanding | ||||||||||||||||||||
| Line of Credit Facility, Current Borrowing Capacity, Including Accrued Interest | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Borrowed funds | ||||||||||||||||||||
| Borrowers’ advances for insurance and taxes | ||||||||||||||||||||
| Principal, interest, and related escrow owed on loans serviced | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 100,000,000 shares authorized, none issued and outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value, 700,000,000 shares authorized; 332,318,750 shares issued; 280,440,995 and 280,590,497 outstanding at June 30, 2026 and September 30, 2025, respectively | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost; 51,877,755 and 51,728,253 shares at June 30, 2026 and September 30, 2025, respectively | ||||||||||||||||||||
| Unallocated ESOP shares | ||||||||||||||||||||
| Retained earnings—substantially restricted | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...
